Академический Документы
Профессиональный Документы
Культура Документы
a r t i c l e
i n f o
Article history:
Received 17 November 2012
Received in revised form 8 April 2013
Accepted 27 April 2013
Keywords:
Artemisinin biosynthesis pathway
Overexpression of ADS, CYP71AV1 and CPR
Southern blot
Real-time quantitative PCR
High-performance liquid chromatography
a b s t r a c t
Artemisinin is an effective anti-malarial drug isolated from A. annua, which has an enormous commercialization demand all over the world. However, the low artemisinin content of A. annua greatly limits
the commercialization of artemisinin. In this study, we report the results of our experiments, where
for the rst time we have achieved the overexpression of ADS, CYP71AV1 and CPR genes in A. annua.
Eight transgenic A. annua plants were obtained through Agrobacterium tumefaciens-mediated transformation, which was conrmed by PCR. Southern-blot analyses showed that some of the transgenic lines
had low copies of the integration transgenes. The results of real time-qPCR showed that the expression
levels of ADS, CYP71AV1 and CPR genes were signicantly increased, too. The HPLC analyses showed that
the artemisinin contents were signicantly increased in these transgenic plants. One of the transgenic
plants, ACR16, was found to contain 2.4-fold higher (15.1 mg/g DW) artemisinin than the control plants
(pCAMBIA2300 transgenic plants). All above results showed that overexpression of ADS, CYP71AV1 and
CPR genes in A. annua could promoted the metabolic ux ows toward biosynthesis of artemisinin and
effectively increase the level of artemisinin content in transgenic A. annua plants.
2013 Elsevier B.V. All rights reserved.
1. Introduction
Artemisia annua is an annual herbaceous plant in the family Asteraceae, which is capable of producing a wide range of
terpenoids including artemisinin. Artemisinin, a sesquiterpene lactone, is currently the best therapeutic against both drug-resistant
and cerebral malaria-causing strains of Plasmodium falciparum
(Weathers et al., 2006). Malaria is a global health problem with
more than 1 billion people living in areas with a high risk of the
disease (Graham et al., 2010). So, there is an enormous demand
for the supply of artemisinin all over the world. However, the
artemisinin content of A. annua is very low (0.010.8% dry wt) and
this limits the commercialization of artemisinin greatly (Lei et al.,
2011).
With the elucidation of the biosynthetic pathway of
artemisinin, several key enzymatic genes involved in artemisinin
381
Table 1
Primers used in this study.
Primers
Purpose
1304F
1304R
P35S
ADSR2
CYPR2
CPRR2
NPTIIR2
ADSF4
ADSR4
CYPF4
CYPR4
CPRF4
CPRR4
Actin-F
Actin-R
PCR
PCR
PCR
PCR
PCR
PCR
PCR
RT-Q-PCR
RT-Q-PCR
RT-Q-PCR, Probe
RT-Q-PCR, Probe
RT-Q-PCR
RT-Q-PCR
RT-Q-PCR
RT-Q-PCR
ATTTAAATCAGGAGTCAAAGATCAAA
GCTGCAGCCCCGGGGCCCGATCTAGTAACATAGAT
TTCGTCAACATGGTGGAGCA
AGTGCCCGTTGTATTTCG
GGAAGGCTTTTTTTGGTGGATTTG
CTTCCGTCCGTCATCAACCTCA
CCCTGATGCTCTTCGTCCA
AATGGGCAAATGAGGGACAC
TTTCAAGGCTCGATGAACTATG
CACCCTCCACTACCCTTG
GACACATCCTTCTCCCAGC
AGCCTCTTTGCCACCTCCT
GAACAGACTCCCTTGTGAACG
CCAGGCTGTTCAGTCTCTGTAT
CGCTCGGTAAGGATCTTCATCA
Fig. 1. The biosynthesis pathway of artemisinin. ADS, amorpha-4,11-diene synthase; CYP71AV1, cytochrome P450 dependent hydroxylase; CPR, cytochrome P450
oxidoreductase; DBR2, double bond reductase 2; ALDH1, aldehyde dehydrogenase.
382
383
Fig. 2. Obtainment of transgenic A. annua plants. (A) Obtainment of kanamycin-resistant plants through selecting on MS medium with 50 mg/L kanamycin. (B) Regeneration
of transgenic A. annua plants. (C) Rooting of transgenic A. annua plants. (D) Transplantation of partial transgenic A. annua plants.
template. Under the same condition, eight transgenic lines ACR1, ACR-8, ACR-10, ACR-16, ACR-30, ACR-31, ACR-52 and ACR-53
could generate the 1027-bp products after PCR amplication, which
did not show up with transgenic plants of empty vector and nontransgenic plants as template (Fig. 3A). Likewise, using F35S and
CYP71AV1-specic primer CYPR2, CPR-specic primer CPRR2, the
580-bp and 729-bp products were amplied, respectively. The
aimed products were amplied respectively in all the eight transgenic lines (Fig. 3B and C). A 635-bp product could be amplied
from all the transgenic A. annua with F35S and NPTIIR2 as primers,
which could not be amplied from non-transgenic plants under the
same amplication condition (Fig. 3D). The above results validated
the existence of NPTII gene and 35S-promoted ADS, CYP71AV1 and
CPR genes in transgenic A. annua.
Fig. 3. Polymerase chain reaction detection of ADS, CYP71AV1, CPR and NPTII gene
in transgenic A. annua plants. Primers used for detecting were F35S, ADSR2, CYPR2,
CPRR2 and NPTIIR2. Total genomic DNA was isolated from young leaves by CTAB
method. Plasmid DNA from the Agrobacterium carrying pCAMBIA2300 + ACR was
used as a positive control. M, DNA size marker DL2000; V, A. annua plant transformed with blank pCAMBIA2300; C, wild-type A. annua; , water control; +, positive
control. Numbers indicate the lines of transgenic A. annua (e.g. 1 indicates ACR1).
384
Fig. 5. Expression prole analysis of ADS, CYP71AV1 and CPR by RT-Q-PCR. Transgenic lines: ACR1, ACR8, ACR10, ACR16, ACR30, ACR31, ACR51 and ACR52; vector,
blank pCAMBIA2300 transgenic plants. RT-Q-PCR analysis was performed with Actin
as internal control.
Fig. 6. Artemisinin content in different lines. Artemisinin content analysis was performed by HPLC. Transgenic lines: ACR1, ACR8, ACR10, ACR16, ACR30, ACR31, ACR51
and ACR52; vector, blank pCAMBIA2300 transgenic plants. Data are the means of
determinations of the three copies of each transgenic line. Vertical bars represent
standard deviation.
ACR16 at 15.1 mg/g DW, which was 2.4-fold than that of control
plants (pCAMBIA2300 transgenic plants).
4. Conclusions
In the study, the transgenic A. annua plants accumulating in
excess of 50140% artemisinin from a commercially cultivated crop
were achieved. Artemisinin accumulation was highest in transgenic
line ACR16 at 15.1 mg/g DW. Although the biosynthetic ability of
artemisinin were varied in different transgenic plants, the higher
accumulation trend of artemisinin which was resulted from the
overexpression of ADS, CYP71AV1 and CPR genes in transgenic
plants should not be denied. In a word, this study suggested that
the overexpression of ADS, CYP71AV1 and CPR genes were able to
break the limited enzymatic steps in artemisinin biosynthesis pathway, and promoted the metabolic ux ows toward biosynthesis
of artemisinin in transgenic plants.
Acknowledgments
This work was funded by China 863 Program (Grant no.
2011AA100605), China Transgenic Research Program (Grant no.
2011ZX08002-001), Ministry of Education.
References
Alam, P., Abdin, M.Z., 2011. Over-expression of HMG-CoA reductase and amorpha4,11-diene synthase genes in Artemisia annua L. and its inuence on artemisinin
content. Plant Cell Rep. 30, 19191928.
Banyai, W., Kirdmanee, C., Mii, M., Supaibulwatana, K., 2010. Overexpression of
farnesyl pyrophosphate synthase (FPS) gene affected artemisinin content and
growth of Artemisia annua L. Plant Cell Tiss. Organ Cult. 103, 255265.
Bouwmeester, H.J., Wallaart, T.E., Janssen, M.H., Van Loo, B., Jansen, B.J., Posthumus,
M.A., Schmidt, C.O., De Kraker, J.W., Konig, W.A., Franssen, M.C., 1999. Amorpha4,11-diene synthase catalyses the rst probable step in artemisinin biosynthesis.
Phytochemistry 52, 843854.
385